Population aging is magnifying the global burden of cardiometabolic disorders and their consequences. Global cardiometabolic risk represents the overall risk of developing type 2 diabetes and/or cardiovascular diseases due to a cluster of risk factors. Development of clinically useful primary and secondary prevention strategies will require a more comprehensive understanding of these complex conditions. We aim to investigate the association of traditional and novel risk factors, representing of different pathophysiologic pathways, with cardiometabolic risk using population-based data. Besides contribution of various pathways, as well as their interactions, to form the natural course of cardiometabolic disorders, differences between women and men in these processes are of interest. A successful candidate will have an interest in population-based studies and analyses of large-scale epidemiological databases including the omics-based approaches.

We are looking for a highly motivated candidate with a master's degree in Medicine. Experience with (omics-based) epidemiological methods (MSc in Health Sciences) is a strength. A strong command of English is required.

Being able to present a certificate of good conduct, a valid proof of identity, diploma's and/or relevant registration such as BIG/RGS are conditions for the appointment.

We offer a temporary position up to a period of 3.5 years. The gross monthly salary amounts a maximum of
€ 4.216,- (scale 10) depending on level of education and relevant experience and based on a full-time working week of 36 hours. The terms of employment are in accordance with the Collective Bargaining Agreement for University Medical Centers (CAO UMC).

Erasmus MC

Erasmus MC stands for a healthy population and excellence in healthcare. By conducting groundbreaking work, we aim to push boundaries through leading the way in research, education and healthcare. We have access to the latest equipment and techniques in a state-of-the-art environment.

The candidate will be appointed at the Department of Epidemiology and will be working in the researchline of Cardiometabolic Epidemiology. The research will be conducted in the Rotterdam Study, an on-going population-based cohort study that began in 1990 and now follows nearly 15,000 older adults. More information on this study can be found on the Rotterdam Study website.